Related Experiment Video
Updated: Aug 3, 2025
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
Ali Osman Gulmez1, Sonay Aydin2
1Department of Radiology, Erzincan University, Erzincan 24100, Turkey. aliosmangulmez.2@gmail.com.
Insights
Understanding the link between coronavirus disease-19 (COVID-19) and heart conditions is crucial. Cardiac biomarkers and imaging aid in diagnosing COVID-19, predicting its course, and assessing patient outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Biomarkers
Background:
- The link between COVID-19 and cardiovascular diseases is a significant clinical concern.
- Cardiac biomarkers and imaging are vital for diagnosing COVID-19 and managing patients.
Purpose of the Study:
- To elucidate the role of cardiac biomarkers in the context of COVID-19.
- To understand how biomarkers inform diagnosis, prognosis, and outcomes in COVID-19 patients.
Main Methods:
- Review of current literature on cardiac biomarkers in COVID-19.
- Analysis of diagnostic and prognostic implications of cardiac biomarkers.
Main Results:
- Cardiac biomarkers are essential for assessing cardiac injury in COVID-19 patients.
- Biomarker levels correlate with disease severity and patient outcomes.
Conclusions:
- Cardiac biomarkers play a critical role in the comprehensive management of COVID-19.
- Understanding biomarker patterns aids in predicting disease trajectory and improving patient care.
Abstract:
The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can understand the diagnosis of the disease, the predicted course and results after diagnosis.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies